Evidence map›Paper›PMID 36577721›Full record

ArticleAddiction biology2023

Dissecting the epigenomic differences between smoking and nicotine dependence in a veteran cohort.

Sheila Tiemi Nagamatsu, Robert H Pietrzak, Ke Xu, John H Krystal, Joel Gelernter, Janitza Liz Montalvo-Ortiz

Open access · greenAbstract read
In one paragraph

Article in Addiction biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Epigenetic Signatures of Smoking in Five Brain Regions.Journal of personalized medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sheila Tiemi NagamatsuDivision of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-4986-5094
Robert H PietrzakDivision of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Ke XuDivision of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-6472-7052
John H KrystalDivision of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Joel GelernterDivision of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-4067-1859
Janitza Liz Montalvo-OrtizDivision of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
United States Department of Veterans Affairs · USYale University · US

Funding

Translational Technologies CoreP50AA012870 · NIAAA · YALE UNIVERSITY · PI John H. Krystal · 2001 to 2026
$43.7M
Sex-specific analysis of opioid dependence GWAS and beyondR01DA012690 · NIDA · YALE UNIVERSITY · PI GELERNTER, JOEL · 2000 to 2017
$14.0M
A Translational and Neurocomputational Evaluation of a D1R Partial Agonist for SchizophreniaU01MH121766 · NIMH · YALE UNIVERSITY · PI KRYSTAL, JOHN H. · 2019 to 2022
$11.8M
Cost and Health Outcomes of Risky Drinking in an HMOR01AA012890 · NIAAA · KAISER FOUNDATION RESEARCH INSTITUTE · PI LYNCH, FRANCES L · 2002 to 2004
$790k
Integrative Epigenomic Mapping of Co-Morbid OUD and PTSD SupplementR21DA050160 · NIDA · YALE UNIVERSITY · PI MONTALVO-ORTIZ, JANITZA LIZ · 2020 to 2021
$433k
Identifying Biomarkers of Post-traumatic Stress Disorder in U.S. Veterans using an Integrative Multi-Omics ApproachIK2CX002095 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI Janitza Liz Montalvo-Ortiz · 2020 to 2026
–
BLRD VA I01 BX006482CSRD VA I01 CX001849CSRD VA IK2 CX002095NIAAA NIH HHS P50 AA012870NIAAA NIH HHS R01 AA012890NIDA NIH HHS R01 DA012690NIDA NIH HHS R21 DA050160NIMH NIH HHS U01 MH121766
6 · The paper itself

Abstract

Smoking is a serious public health issue linked to more than 8 million deaths per year worldwide and may lead to nicotine dependence (ND). Although the epigenomic literature on smoking is well established, studies evaluating the role of epigenetics in ND are limited. In this study, we examined the epigenomic signatures of ND and how these differ from smoking exposure to identify biomarkers specific to ND. We investigated the peripheral epigenetic profile of smoking status (SS) and ND in a US male veteran cohort. DNA from saliva was collected from 1135 European American (EA) male US military veterans. DNAm was assessed using the Illumina Infinium Human MethylationEPIC BeadChip array. SS was evaluated as current smokers (n = 137; 12.1%) and non-current smokers (never and former; n = 998; 87.9%). ND

Indexed as

Tobacco Use DisorderVeteransBiomarkersDNA MethylationEpigenomicsHumansMaleSmokingBiomarkersDNA methylationepigenomicsnicotine dependencesmokingveterans

Identifiers

PMID36577721
PMCPMC12120967
OpenAlexW4311044003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.